Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Long-term Follow-up Study of Subjects Who Received CRISPR CAR T Cellular TherapiesHemic and Lymphatic Diseases, Neoplasms by Site, hematologic disorder, hematopoietic and lymphoid system neoplasm, neoplasmEnrolling by invitationNot stated2026-09-24NCT06208878

1 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
CRISPR Therapeutics AG5

24 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Alfred HealthMelbourneAustralia9
Cedars SinaiLos AngelesUnited States21
City of HopeDuarteUnited States238
EmoryAtlantaUnited States9
Epworth HealthcareRichmondAustralia1
MD Anderson Cancer CenterHoustonUnited States589
Methodist Hospital-Sarah CannonSan AntonioUnited States1
Montefiore Medical CenterThe BronxUnited States198
MSKCCNew YorkUnited States5
Oregon Health and Science UniversityPortlandUnited States382
Peter MacCallum Cancer CenterMelbourneAustralia12
Princess MargaretTorontoCanada2
Royal Prince Alfred HospitalCamperdownAustralia83
Sir Charles GairdnerNedlandsAustralia1
StanfordStanfordUnited States4
University Hospital Hamburg-EppendorfHamburgGermany1
University of ChicagoChicagoUnited States312
University of KansasWestwoodUnited States10
University of MinnesotaMinneapolisUnited States325
University of PennsylvaniaPhiladelphiaUnited States507
University of Utah-Huntsman Cancer InstituteSalt Lake CityUnited States1
UT SouthwesternDallasUnited States33
Washington University Saint LouisSt LouisUnited States1
Yale New Haven HospitalNew HavenUnited States52